ondansetron has been researched along with Cognition Disorders in 7 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This systematic review identified published studies that evaluated the use of ondansetron in individuals with psychosis associated with dementia." | 8.98 | Is ondansetron beneficial for psychosis associated with dementia?. ( Farheen, SA; Lingamchetty, T; Maksimowski, M; Tampi, RR, 2018) |
| "This systematic review identified published studies that evaluated the use of ondansetron in individuals with psychosis associated with dementia." | 4.98 | Is ondansetron beneficial for psychosis associated with dementia?. ( Farheen, SA; Lingamchetty, T; Maksimowski, M; Tampi, RR, 2018) |
| "Ondansetron was without effect on working memory errors, but significantly increased the number of reference memory errors made by the ex-ethanol group." | 1.29 | The role of 5-HT in the anxiogenic effects of acute ethanol withdrawal and in the long-lasting cognitive deficits. ( al-Farhan, M; Andrews, N; File, SE; Wu, PY, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tampi, RR | 1 |
| Maksimowski, M | 1 |
| Lingamchetty, T | 1 |
| Farheen, SA | 1 |
| Papadopoulos, G | 1 |
| Pouangare, M | 1 |
| Papathanakos, G | 1 |
| Arnaoutoglou, E | 1 |
| Petrou, A | 1 |
| Tzimas, P | 1 |
| Lirk, P | 1 |
| Hollmann, MW | 1 |
| Sharma, A | 1 |
| Muresanu, DF | 1 |
| Lafuente, JV | 1 |
| Patnaik, R | 1 |
| Tian, ZR | 1 |
| Buzoianu, AD | 1 |
| Sharma, HS | 1 |
| Akhondzadeh, S | 1 |
| Mohammadi, N | 1 |
| Noroozian, M | 1 |
| Karamghadiri, N | 1 |
| Ghoreishi, A | 1 |
| Jamshidi, AH | 1 |
| Forghani, S | 1 |
| Hashimoto, K | 1 |
| Fujita, Y | 1 |
| Ishima, T | 1 |
| Hagiwara, H | 1 |
| Iyo, M | 1 |
| File, SE | 1 |
| Andrews, N | 1 |
| al-Farhan, M | 1 |
| Wu, PY | 1 |
1 review available for ondansetron and Cognition Disorders
| Article | Year |
|---|---|
Is ondansetron beneficial for psychosis associated with dementia?.
Topics: Antipsychotic Agents; Cognition Disorders; Dementia; Humans; Ondansetron; Parkinson Disease; Psychot | 2018 |
2 trials available for ondansetron and Cognition Disorders
| Article | Year |
|---|---|
The effect of ondansetron on postoperative delirium and cognitive function in aged orthopedic patients.
Topics: Aged; Anesthesia, General; Cognition Disorders; Delirium; Double-Blind Method; Female; Femoral Fract | 2014 |
Added ondansetron for stable schizophrenia: a double blind, placebo controlled trial.
Topics: Adult; Antipsychotic Agents; Case-Control Studies; Chronic Disease; Cognition Disorders; Double-Blin | 2009 |
4 other studies available for ondansetron and Cognition Disorders
| Article | Year |
|---|---|
Ondansetron: a new therapeutic option to attenuate postoperative cognitive dysfunction and delirium?
Topics: Cognition Disorders; Delirium; Female; Humans; Male; Ondansetron; Postoperative Complications; Serot | 2014 |
Sleep Deprivation-Induced Blood-Brain Barrier Breakdown and Brain Dysfunction are Exacerbated by Size-Related Exposure to Ag and Cu Nanoparticles. Neuroprotective Effects of a 5-HT3 Receptor Antagonist Ondansetron.
Topics: Animals; Blood Proteins; Blood-Brain Barrier; Brain; Brain Chemistry; Brain Edema; Cognition Disorde | 2015 |
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: role of alpha7 nicotinic receptors.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Cognition Disorders; Excitatory Amino Acid Antagon | 2006 |
The role of 5-HT in the anxiogenic effects of acute ethanol withdrawal and in the long-lasting cognitive deficits.
Topics: Animals; Anxiety; Buspirone; Cognition Disorders; Ethanol; Exploratory Behavior; Hippocampus; In Vit | 1993 |